392 results on '"Dirix, Luc Y."'
Search Results
2. Pathway-based subnetworks enable cross-disease biomarker discovery.
3. A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors
4. Pathological features of vessel co-option versus sprouting angiogenesis
5. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases
6. Supplementary Figure 1 from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
7. Supplementary Figure 3A from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
8. Supplementary Table 3C from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
9. Supplementary Table 1 from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
10. Data from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
11. Supplementary Table 2 from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
12. Supplementary Figure 2A from Regulation of Inflammatory Breast Cancer Cell Invasion through Akt1/PKBα Phosphorylation of RhoC GTPase
13. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC)
14. Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
15. Supplementary Table 2 from Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
16. Supplementary Tables S1-S2 from mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
17. Supplementary Figures S1-S2 from mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
18. Supplementary Table 3 from Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
19. Supplementary Table 1 from Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node–Negative Breast Cancer
20. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
21. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
22. Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized study
23. Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer
24. Angiogenesis and Lymphangiogenesis in IBC: Insights from a Genome-Wide Gene Expression Profiling Study
25. The Effect of Systemic Chemotherapy on Minimal Residual Disease in the Blood and Bone Marrow of Patients with Inflammatory Breast Cancer
26. Clinicopathological Analysis of Lymphatic Vessels and of Lymphangiogenesis in Human Cancer
27. Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
28. Peritumoral D2–40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma
29. Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
30. The histological growth pattern of colorectal cancer liver metastases has prognostic value
31. VEGF-A-independent and angiogenesis-dependent tumour growth in patients with metastatic breast cancer
32. Contribution of ER and NF-κB to endocrine resistance in inflammatory breast cancer
33. Differential expression of hypoxia and (lymph)angiogenesis-related genes at different metastatic sites in breast cancer
34. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling
35. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer
36. Distinct Molecular Signature of Inflammatory Breast Cancer by cDNA Microarray Analysis
37. Pharmacokinetics of tipifarnib after oral and intravenous administration in subjects with advanced cancer
38. The Presence of a Fibrotic Focus in Invasive Breast Carcinoma Correlates with the Expression of Carbonic Anhydrase IX and is a Marker of Hypoxia and Poor Prognosis
39. AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney: A randomized, double-blind, placebo-controlled, phase 2 study
40. Prognostic Significance of Disseminated Tumor Cells as Detected by Quantitative Real-Time Reverse-Transcriptase Polymerase Chain Reaction in Patients with Breast Cancer
41. cDNA Microarray Analysis of Inflammatory Breast Cancer Signatures
42. Clinicopathological Analysis of Lymphatic Vessels and of Lymphangiogenesis in Human Cancer
43. Abstract P3-01-13: Association between the histopathological growth patterns (HGP) of liver metastases (LM) and survival after hepatic surgery in patients with oligometastatic breast cancer (BC)
44. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: A review of the current knowledge
45. Is there a role for mammary stem cells in inflammatory breast carcinoma?: A review of evidence from cell line, animal model, and human tissue sample experiments
46. Pathological features of vessel co-option versus sprouting angiogenesis
47. Re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548–51
48. Two distinct expression patterns of urokinase, urokinase receptor and plasminogen activator inhibitor-1 in colon cancer liver metastases
49. Re: Anti–Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells
50. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.